InterOcean Capital LLC raised its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 16.7% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 1,184 shares of the healthcare conglomerate’s stock after purchasing an additional 169 shares during the period. InterOcean Capital LLC’s holdings in UnitedHealth Group were worth $295,000 at the end of the most recent quarter.
Several other institutional investors have also bought and sold shares of the business. Country Trust Bank lifted its holdings in shares of UnitedHealth Group by 556.3% during the first quarter. Country Trust Bank now owns 105 shares of the healthcare conglomerate’s stock valued at $26,000 after purchasing an additional 89 shares in the last quarter. Tobias Financial Advisors Inc. purchased a new position in UnitedHealth Group in the 4th quarter worth about $29,000. RMR Wealth Builders bought a new position in UnitedHealth Group during the 4th quarter valued at about $29,000. HBC Financial Services PLLC purchased a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $30,000. Finally, Lion Street Advisors LLC purchased a new stake in shares of UnitedHealth Group during the 1st quarter valued at about $31,000. 87.10% of the stock is owned by institutional investors and hedge funds.
A number of research analysts recently weighed in on UNH shares. Deutsche Bank lowered their price objective on shares of UnitedHealth Group from $308.00 to $293.00 and set a “buy” rating on the stock in a research report on Thursday, April 16th. Citigroup decreased their target price on shares of UnitedHealth Group from $346.00 to $339.00 and set a “buy” rating for the company in a research note on Friday, April 24th. Cowen raised their price target on UnitedHealth Group from $320.00 to $340.00 and gave the stock an “outperform” rating in a research note on Thursday, April 16th. Stephens lifted their price objective on UnitedHealth Group from $300.00 to $310.00 and gave the stock an “overweight” rating in a report on Wednesday, April 15th. Finally, Credit Suisse Group lowered their target price on UnitedHealth Group from $330.00 to $325.00 and set an “outperform” rating on the stock in a report on Thursday, April 16th. Four investment analysts have rated the stock with a hold rating and twenty have given a buy rating to the company’s stock. UnitedHealth Group currently has an average rating of “Buy” and an average target price of $319.68.
NYSE UNH traded up $3.03 on Friday, reaching $289.94. 2,907,540 shares of the stock were exchanged, compared to its average volume of 4,276,896. The company has a current ratio of 0.75, a quick ratio of 0.75 and a debt-to-equity ratio of 0.60. UnitedHealth Group Inc has a one year low of $187.72 and a one year high of $306.71. The firm has a market capitalization of $272.10 billion, a PE ratio of 20.29, a PEG ratio of 1.41 and a beta of 0.72. The company’s 50-day simple moving average is $277.58 and its two-hundred day simple moving average is $277.14.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Wednesday, April 15th. The healthcare conglomerate reported $3.72 earnings per share for the quarter, topping the Zacks’ consensus estimate of $3.63 by $0.09. The business had revenue of $64.40 billion during the quarter, compared to analyst estimates of $64.25 billion. UnitedHealth Group had a net margin of 5.59% and a return on equity of 24.86%. The company’s revenue was up 6.8% on a year-over-year basis. During the same period in the prior year, the business posted $3.73 earnings per share. Sell-side analysts forecast that UnitedHealth Group Inc will post 16.24 earnings per share for the current fiscal year.
In related news, Director Stephen J. Hemsley sold 45,637 shares of the stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $289.11, for a total transaction of $13,194,113.07. Following the completion of the sale, the director now owns 1,013,122 shares in the company, valued at $292,903,701.42. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Richard T. Burke sold 5,000 shares of UnitedHealth Group stock in a transaction that occurred on Monday, March 16th. The shares were sold at an average price of $237.00, for a total value of $1,185,000.00. Following the sale, the director now directly owns 1,406,500 shares in the company, valued at approximately $333,340,500. The disclosure for this sale can be found here. Over the last three months, insiders have sold 65,637 shares of company stock worth $17,723,013. Insiders own 0.80% of the company’s stock.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Article: What is the CAC 40 Index
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.